Pelthos Therapeutics Inc. revenue
Pelthos Therapeutics Inc.'s revenue was $16.8m in fiscal 2025. Over the last twelve months it was $43.3m.
Revenue history
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Commercial Operations | $16.2M | 96.5% | — |
| Research and Development Operations | $589,000 | 3.5% | — |
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Net Product | $16.2M | 96.5% | — |
| License and Collaboration | $589,000 | 3.5% | — |
From Pelthos Therapeutics Inc.'s 10-K filed March 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Pelthos Therapeutics Inc. | $43.3m | — | — |
| Biofrontera Inc. | $46.2m | 17.8% | 16.7% |
| Cumberland Pharmaceuticals Inc | $39.9m | -5.2% | -0.6% |
| IM Cannabis Corp. | $39.2m | -0.7% | — |
| BGM Group Ltd. | $37.9m | 51.1% | — |
| Sunshine Biopharma Inc. | $35.3m | -2.7% | 34.5% |
Compare with peers
- Biofrontera Inc. revenue
- Cumberland Pharmaceuticals Inc revenue
- IM Cannabis Corp. revenue
- BGM Group Ltd. revenue
- Sunshine Biopharma Inc. revenue
Head to head: BFRI vs PTHSCPIX vs PTHSIMCC vs PTHS
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies